FdaApplication
BLA 125646
Identifiers
- fda_app_no: BLA125646
Properties
| Property | Value |
|---|---|
| applicant_name | Novartis Pharmaceuticals Corporation |
| application_type | BLA |
| approval_date | 2017-08-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KYMRIAH | — | 0.6 to 6.0 x 10^8 CAR-POSITIVE VIABLE T CELLS | Injection |
1 product